Inspire Medical Systems, Inc. (INSP)

$241.66

-1.95

(-0.8%)▲

Market is closed - opens 7 PM, 01 May 2024

Insights on Inspire Medical Systems, Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 127.89M → 192.50M (in $), with an average increase of 12.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -15.42M → 14.76M (in $), with an average increase of 75.6% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 36.1% return, outperforming this stock by 43.9%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 64.8% return, outperforming this stock by 62.8%

Performance

  • $240.94
    $244.82
    $241.66
    downward going graph

    0.3%

    Downside

    Day's Volatility :1.58%

    Upside

    1.29%

    downward going graph
  • $123.27
    $330.00
    $241.66
    downward going graph

    48.99%

    Downside

    52 Weeks Volatility :62.65%

    Upside

    26.77%

    downward going graph

Returns

PeriodInspire Medical Systems, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
12.67%
-1.3%
0.0%
6 Months
54.58%
12.4%
0.0%
1 Year
-7.8%
4.6%
0.0%
3 Years
2.62%
15.7%
-21.9%

Highlights

Market Capitalization
7.0B
Book Value
$19.37
Earnings Per Share (EPS)
-0.72
Wall Street Target Price
254.88
Profit Margin
-3.39%
Operating Margin TTM
4.83%
Return On Assets TTM
-4.05%
Return On Equity TTM
-3.96%
Revenue TTM
624.8M
Revenue Per Share TTM
21.32
Quarterly Revenue Growth YOY
39.6%
Gross Profit TTM
341.7M
EBITDA
-37.4M
Diluted Eps TTM
-0.72
Quarterly Earnings Growth YOY
3.68
EPS Estimate Current Year
-0.36
EPS Estimate Next Year
0.62
EPS Estimate Current Quarter
-0.1
EPS Estimate Next Quarter
-0.53

Analyst Recommendation

Buy
    76%Buy
    23%Hold
    0
    0%Sell
Based on 21 Wall street analysts offering stock ratings for Inspire Medical Systems, Inc.(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
17
Hold
5
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 5.47%

Current $241.66
Target $254.88

Company Financials

FY18Y/Y Change
Revenue
50.6M
↑ 77.1%
Net Income
-21.8M
↑ 24.65%
Net Profit Margin
-43.14%
↑ 18.16%
FY19Y/Y Change
Revenue
82.1M
↑ 62.18%
Net Income
-33.2M
↑ 52.3%
Net Profit Margin
-40.52%
↑ 2.62%
FY20Y/Y Change
Revenue
115.4M
↑ 40.62%
Net Income
-57.2M
↑ 72.08%
Net Profit Margin
-49.58%
↓ 9.06%
FY21Y/Y Change
Revenue
233.4M
↑ 102.28%
Net Income
-42.0M
↓ 26.5%
Net Profit Margin
-18.01%
↑ 31.57%
FY22Y/Y Change
Revenue
407.9M
↑ 74.75%
Net Income
-44.9M
↑ 6.75%
Net Profit Margin
-11.0%
↑ 7.01%
FY23Y/Y Change
Revenue
624.8M
↑ 53.19%
Net Income
-21.2M
↓ 52.87%
Net Profit Margin
-3.39%
↑ 7.61%
Q3 FY22Q/Q Change
Revenue
109.2M
↑ 19.48%
Net Income
-16.8M
↑ 16.27%
Net Profit Margin
-15.43%
↑ 0.43%
Q4 FY22Q/Q Change
Revenue
137.9M
↑ 26.3%
Net Income
3.2M
↓ 118.7%
Net Profit Margin
2.28%
↑ 17.71%
Q1 FY23Q/Q Change
Revenue
127.9M
↓ 7.25%
Net Income
-15.4M
↓ 589.65%
Net Profit Margin
-12.06%
↓ 14.34%
Q2 FY23Q/Q Change
Revenue
151.1M
↑ 18.14%
Net Income
-12.0M
↓ 22.51%
Net Profit Margin
-7.91%
↑ 4.15%
Q3 FY23Q/Q Change
Revenue
153.3M
↑ 1.46%
Net Income
-8.5M
↓ 28.55%
Net Profit Margin
-5.57%
↑ 2.34%
Q4 FY23Q/Q Change
Revenue
192.5M
↑ 25.57%
Net Income
14.8M
↓ 272.87%
Net Profit Margin
7.67%
↑ 13.24%
FY18Y/Y Change
Total Assets
200.1M
↑ 697.42%
Total Liabilities
36.1M
↑ 52.84%
FY19Y/Y Change
Total Assets
181.3M
↓ 9.41%
Total Liabilities
41.4M
↑ 14.79%
FY20Y/Y Change
Total Assets
281.2M
↑ 55.14%
Total Liabilities
51.4M
↑ 24.2%
FY21Y/Y Change
Total Assets
295.1M
↑ 4.94%
Total Liabilities
66.0M
↑ 28.37%
FY22Y/Y Change
Total Assets
564.9M
↑ 91.43%
Total Liabilities
68.9M
↑ 4.29%
FY23Y/Y Change
Total Assets
676.8M
↑ 19.82%
Total Liabilities
104.3M
↑ 51.44%
Q3 FY22Q/Q Change
Total Assets
527.5M
↑ 80.66%
Total Liabilities
57.3M
↓ 11.84%
Q4 FY22Q/Q Change
Total Assets
564.9M
↑ 7.08%
Total Liabilities
68.9M
↑ 20.15%
Q1 FY23Q/Q Change
Total Assets
571.8M
↑ 1.23%
Total Liabilities
67.2M
↓ 2.42%
Q2 FY23Q/Q Change
Total Assets
618.2M
↑ 8.11%
Total Liabilities
88.9M
↑ 32.27%
Q3 FY23Q/Q Change
Total Assets
639.5M
↑ 3.44%
Total Liabilities
95.3M
↑ 7.23%
Q4 FY23Q/Q Change
Total Assets
676.8M
↑ 5.84%
Total Liabilities
104.3M
↑ 9.42%
FY18Y/Y Change
Operating Cash Flow
-18.7M
↑ 18.38%
Investing Cash Flow
-83.4M
↑ 997.22%
Financing Cash Flow
190.4M
↑ 641.92%
FY19Y/Y Change
Operating Cash Flow
-32.8M
↑ 75.7%
Investing Cash Flow
-43.6M
↓ 47.76%
Financing Cash Flow
2.0M
↓ 98.97%
FY20Y/Y Change
Operating Cash Flow
-53.0M
↑ 61.5%
Investing Cash Flow
86.6M
↓ 298.87%
Financing Cash Flow
134.1M
↑ 6726.12%
FY21Y/Y Change
Operating Cash Flow
-20.1M
↓ 62.07%
Investing Cash Flow
29.1M
↓ 66.36%
Financing Cash Flow
14.9M
↓ 88.85%
FY22Y/Y Change
Operating Cash Flow
11.6M
↓ 157.5%
Investing Cash Flow
-19.6M
↓ 167.25%
Financing Cash Flow
235.1M
↑ 1472.63%
Q3 FY22Q/Q Change
Operating Cash Flow
11.0M
↓ 284.78%
Investing Cash Flow
-3.8M
↓ 67.05%
Financing Cash Flow
224.1M
↑ 36107.59%
Q4 FY22Q/Q Change
Operating Cash Flow
19.3M
↑ 75.14%
Investing Cash Flow
-3.0M
↓ 21.58%
Financing Cash Flow
7.3M
↓ 96.75%
Q1 FY23Q/Q Change
Operating Cash Flow
-1.3M
↓ 106.97%
Investing Cash Flow
-3.8M
↑ 27.22%
Financing Cash Flow
5.6M
↓ 22.75%
Q2 FY23Q/Q Change
Operating Cash Flow
5.1M
↓ 478.87%
Investing Cash Flow
4.9M
↓ 230.43%
Financing Cash Flow
14.9M
↑ 165.21%
Q3 FY23Q/Q Change
Operating Cash Flow
3.6M
↓ 28.55%
Investing Cash Flow
-144.2M
↓ 3046.7%
Financing Cash Flow
3.5M
↓ 76.56%

Technicals Summary

Sell

Neutral

Buy

Inspire Medical Systems, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
15.28%
54.58%
-7.8%
2.62%
382.55%
Stryker Corporation
Stryker Corporation
-4.45%
23.69%
12.21%
27.9%
80.24%
Boston Scientific Corp.
Boston Scientific Corp.
5.54%
39.12%
36.12%
64.73%
97.55%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-8.81%
34.65%
-1.83%
-9.17%
47.02%
Abbott Laboratories
Abbott Laboratories
-5.46%
11.54%
-4.63%
-11.34%
34.58%
Medtronic Plc
Medtronic Plc
-7.08%
14.13%
-10.83%
-38.37%
-8.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
NA
NA
NA
-0.36
-0.04
-0.04
NA
19.37
Stryker Corporation
Stryker Corporation
40.83
40.83
2.92
11.85
0.18
0.07
0.01
48.92
Boston Scientific Corp.
Boston Scientific Corp.
68.14
68.14
1.8
2.25
0.09
0.04
NA
13.16
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.58
37.58
5.19
2.75
0.21
0.12
NA
11.83
Abbott Laboratories
Abbott Laboratories
33.3
33.3
5.99
4.6
0.15
0.06
0.02
22.26
Medtronic Plc
Medtronic Plc
25.52
25.52
1.52
5.2
0.08
0.04
0.03
38.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc.
Buy
$7.1B
382.55%
NA
-3.39%
Stryker Corporation
Stryker Corporation
Buy
$128.2B
80.24%
40.83
15.44%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$107.2B
97.55%
68.14
11.18%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.0B
47.02%
37.58
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$185.5B
34.58%
33.3
13.96%
Medtronic Plc
Medtronic Plc
Buy
$106.7B
-8.44%
25.52
13.0%

Institutional Holdings

  • FMR Inc

    10.75%

  • Vanguard Group Inc

    9.68%

  • BlackRock Inc

    5.94%

  • Wellington Management Company LLP

    4.72%

  • Baillie Gifford & Co Limited.

    4.06%

  • Wasatch Advisors LP

    3.62%

Corporate Announcements

  • Inspire Medical Systems, Inc. Earnings

    Inspire Medical Systems, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.

Organization
Inspire Medical Systems, Inc.
Employees
1011
CEO
Mr. Timothy P. Herbert
Industry
Health Technology

Discover More

FAQs